Literature DB >> 18584303

Promotion of behavioural change in people with hypertension: an intervention study.

Daniela Scala1, Maria D'Avino, Santolo Cozzolino, Antonio Mancini, Barbara Andria, Giuseppe Caruso, Gianfranco Tajana, Domenico Caruso.   

Abstract

OBJECTIVE: To assess the efficacy of a comprehensive motivational approach in reducing blood pressure in Italian patients with hypertension.
METHOD: Two hundred and ninety-two first visit patients with hypertension without diabetes and dyslipidemia and with BMI < 28 were enrolled. One hundred and forty-two were randomly assigned to a Control group (C) and 150 to an Intervention group (I). A ten-multiple-choice questionnaire was developed to evaluate the effect of the intervention on lifestyle modification. Patients were given the questionnaire, had their BP measured and drug therapy registered before educational intervention and 12 months later. Group I patients participated in the focus group and in the role play 2 and 4 months, respectively, after recruitment. Group C patients received the oral information. MAIN OUTCOME MEASURE: Blood pressure values and lifestyle modification. An intention to treat analysis was undertaken. Analysis was performed using SPSS version 15.0.
RESULTS: Of the 150 group I patients, 58 participated in both focus group and role play, 30 participated only in focus group and the remaining 62 never participated. After 12 months, there was a significant reduction of BP for group I (P < 0.001) and a significant reduction only for systolic BP in group C (P = 0.01). Diastolic BP and systolic BP decreased more markedly in group I than in group C, with P < 0.001 for both. We found a significant improvement of lifestyle modification after 12 months of follow-up concerning some aspects in both groups.
CONCLUSION: Our findings show that a motivational approach is a powerful tool for achieving better blood pressure control and is an essential skill for all healthcare professionals.

Entities:  

Mesh:

Year:  2008        PMID: 18584303     DOI: 10.1007/s11096-008-9235-2

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  22 in total

1.  The COPE Healthy Lifestyles TEEN program: feasibility, preliminary efficacy, & lessons learned from an after school group intervention with overweight adolescents.

Authors:  Bernadette Mazurek Melnyk; Leigh Small; Dianne Morrison-Beedy; Anne Strasser; Lisa Spath; Richard Kreipe; Hugh Crean; Diana Jacobson; Stephanie Kelly; Judith O'Haver
Journal:  J Pediatr Health Care       Date:  2007 Sep-Oct       Impact factor: 1.812

2.  Patients' need for more counseling on diet, exercise, and smoking cessation: results from the National Ambulatory Medical Care Survey.

Authors:  Pamela C Heaton; Stacey M Frede
Journal:  J Am Pharm Assoc (2003)       Date:  2006 May-Jun

3.  Effects of weight status on the recommendations of and adherence to lifestyle modifications among hypertensive adults.

Authors:  K T Xu; R M Ragain
Journal:  J Hum Hypertens       Date:  2005-05       Impact factor: 3.012

4.  A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors.

Authors:  K Margareta Eriksson; Carl-Johan Westborg; Mats C E Eliasson
Journal:  Scand J Public Health       Date:  2006       Impact factor: 3.021

5.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

6.  Understanding of blood pressure by people with type 2 diabetes: a primary care focus group study.

Authors:  Jane Stewart; Ken Brown; Denise Kendrick; Jane Dyas
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

7.  Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.

Authors:  Phayom Sookaneknun; Robert M E Richards; Jaratbhan Sanguansermsri; Chai Teerasut
Journal:  Ann Pharmacother       Date:  2004-11-02       Impact factor: 3.154

8.  Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial.

Authors:  Valerie Burke; Lawrie J Beilin; Hayley E Cutt; Jacqueline Mansour; Amy Wilson; Trevor A Mori
Journal:  J Hypertens       Date:  2005-06       Impact factor: 4.844

9.  The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management.

Authors:  Michele Heisler; Reynard R Bouknight; Rodney A Hayward; Dylan M Smith; Eve A Kerr
Journal:  J Gen Intern Med       Date:  2002-04       Impact factor: 5.128

10.  Perceived adherence to prescribed or recommended standards of care among adults with diabetes.

Authors:  Wendy A Jorgensen; Barbara J Polivka; Terry A Lennie
Journal:  Diabetes Educ       Date:  2002 Nov-Dec       Impact factor: 2.140

View more
  4 in total

1.  Providers' roles in enhancing patients' adherence to pain self management.

Authors:  Lindsey Dorflinger; Robert D Kerns; Stephen M Auerbach
Journal:  Transl Behav Med       Date:  2013-03       Impact factor: 3.046

2.  Reporting of adherence to healthy lifestyle behaviors among hypertensive adults in the 50 states and the District of Columbia, 2013.

Authors:  Jing Fang; Latetia Moore; Fleetwood Loustalot; Quanhe Yang; Carma Ayala
Journal:  J Am Soc Hypertens       Date:  2016-01-11

3.  Using Confocal Microscopy to Generate an Accurate Vascular Model for Use in Patient Education Animation.

Authors:  Angela Douglass; Gillian Moffat; Craig Daly
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Prevalence of taking actions to control blood pressure among adults with self-reported hypertension in 18 states and the District of Columbia, 2009.

Authors:  Carma Ayala; Jing Fang; Keming Yuan
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-03       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.